Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
HA-1004 is an inhibitor of PKG, PKA, myosin light-chain kinase (MLCK), and PKC (Kis = 1.3, 2.3, 70 and 18 µM, respectively, in cell-free assays).1 It induces relaxation of isolated rabbit aortic strips precontracted with histamine (Item No. 33828), serotonin (Item No. 14332), A23187 (Item No. 11016), angiotensin II (Item No. 17150), or prostaglandin F2α (Item No. 16010; EC50s = 0.32-0.63 µM), as well as phenylephrine (Item Nos. 18619 | 17205) with or without calcium (EC50s = 2.3 and 0.5 µM, respectively). HA-1004 also inhibits histamine-induced bronchoconstriction in guinea pigs without affecting blood pressure when administered intratracheally at a dose of 0.1 mg per animal.2
WARNING This product is not for human or veterinary use.
1. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23(21), 5036-5041 (1984).
2. Antibronchoconstrictor activity of the intracellular calcium antagonist HA 1004 in guinea pigs. Pharmacology 37(3), 187-194 (1988).